New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
15:31 EDTCBS, SFM, ALNY, LGF, MELI, POST, AGO, GXP, AL, UBNT, MDVN, SCTY, ED, MNST, NWSA, NVDA, CSC, CFN, DV, SLXP, FRT, SEMGNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include CBS (CBS), consensus 72c; Consolidated Edison (ED), consensus 54c; Monster Beverage (MNST), consensus 75c; News Corporation (NWSA), consensus 3c; NVIDIA (NVDA), consensus 20c; Computer Sciences (CSC), consensus 94c; CareFusion (CFN), consensus 72c;DeVry Education (DV), consensus 67c; Salix Pharmaceuticals (SLXP), consensus $1.72; Federal Realty (FRT), consensus $1.21; SolarCity (SCTY), consensus (99c); Medivation (MDVN), consensus 24c; Sprouts Farmers Market (SFM), consensus 18c; Alnylam Pharmaceuticals (ALNY), consensus (56c); Lions Gate (LGF), consensus 17c; Mercadolibre (MELI), consensus 56c; Post Holdings (POST), consensus 27c; Assured Guaranty (AGO), consensus 35c; Great Plains Energy (GXP), consensus 41c; Air Lease (AL), consensus 52c; Ubiquiti Networks (UBNT), consensus 51c; SemGroup (SEMG), consensus 35c.
News For CBS;ED;MNST;NWSA;NVDA;CSC;CFN;DV;SLXP;FRT;SCTY;MDVN;SFM;ALNY;LGF;MELI;POST;AGO;GXP;AL;UBNT;SEMG From The Last 14 Days
Check below for free stories on CBS;ED;MNST;NWSA;NVDA;CSC;CFN;DV;SLXP;FRT;SCTY;MDVN;SFM;ALNY;LGF;MELI;POST;AGO;GXP;AL;UBNT;SEMG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 8, 2014
11:07 EDTCBSCBS picks James Corden for "Late Late Show," Variety reports
Subscribe for More Information
10:03 EDTLGFLionsgate says Lionsgate UK to assume distribution of Summit films
Lionsgate announced that Lionsgate UK will assume responsibility for the distribution of all Summit label films and will integrate them with the Lionsgate, third-party and locally-produced films it already distributes. The expanded distribution will begin with Summit label films produced after July 2015. The move follows last month's announcement that Lionsgate has moved its international sales headquarters to London. Lionsgate UK's distribution of Summit releases will include Allegiant Part 2, the fourth film in the Divergent franchise, which is slated to begin production in 2016 for worldwide release on March 24, 2017. Distribution of Summit titles in the UK was previously handled by eOne Entertainment. eOne and Lionsgate announced last week that they are extending and expanding their partnership in three territories, with eOne continuing to distribute Lionsgate and Summit films in Canada and Spain and Summit titles in Australia through 2018.
10:03 EDTLGFLionsgate UK expands distribution operations
Subscribe for More Information
09:14 EDTSCTYSolarCity weak since competitor IPO prospectus, says Roth Capital
Subscribe for More Information
08:09 EDTUBNTUbiquiti Networks initiated with an Outperform at FBN Securities
Target $55.
08:03 EDTLGFLionsgate increases quarterly dividend to 7c from 5c
e dividend is payable on November 7 to shareholders of record as of September 30.
07:21 EDTSLXPJazz looks more attractive for Allergan than Salix, says Wells Fargo
Subscribe for More Information
September 5, 2014
08:22 EDTNVDANVIDIA lawsuits likely to have positive outcome, says JMP Securities
After NVIDIA (NVDA) filed lawsuits against Qualcomm (QCOM) and Samsung, JMP Securities thinks there is a good chance that NVIDIA will obtain a favorable ruling or settlement that is equal or greater to the $1.5B deal it cut with Intel (INTC),. The firm thinks that other companies, most notably Apple (AAPL), will launch talks with NVIDIA in the wake of the lawsuit. JMP Securities recommends buying NVIDIA ahead of upcoming Apple product refreshes and what it sees as accelerating growth trends for NVIDIA. The firm is upbeat about NVIDIA's new products and reiterates an Outperform rating.
07:31 EDTNVDANVIDIA lawsuit positive, says Stifel
Subscribe for More Information
September 4, 2014
16:13 EDTNVDANVIDIA files patent infringement complaint against Qualcomm, Samsung
Subscribe for More Information
12:06 EDTSCTYSolarCity volatility at low end of historic range
Subscribe for More Information
11:20 EDTSCTYStocks with increasing options volume
Stocks with increasing options volume: BP VMW SCTY X GE MBLY VALE DDD
09:13 EDTSCTYSolarCity to expand in 7 states, open 20 new operations centers
SolarCity announced plans to open 20 new operations centers in seven states . The new regional operations centers are expected to create more than 600 additional jobs in Arizona, California, Delaware, Maryland, Massachusetts, Nevada and New York. "The new locations will reduce operations costs by decreasing service and installation drive times," the company said.
07:17 EDTCFNCareFusion management to meet with Deutsche Bank
Subscribe for More Information
September 3, 2014
09:05 EDTLGFEntertainment One and Lionsgate renew multi-year film agreements
Subscribe for More Information
September 2, 2014
11:27 EDTSCTYStocks with call strike movement; GRPN SCTY
Groupon (GRPN) January 8 call option implied volatility increased 3% to 54, SolarCity (SCTY) January 82.5 call option implied volatility increased 6% to 52 according to IVolatility.
10:09 EDTMNSTStudy finds adverse heart events associated with energy drinks, ScienceWR says
A study presented at the European Society of Cardiology congress concluded that caffeinated energy drinks can be associated with several adverse heart conditions including angina, cardiac arrhythmia and sudden death, reported Science World Report. Monster Beverage (MNST) markets energy drinks and recently struck a deal to acquire additional energy drink brands from Coca-Cola (KO). PepsiCo also markets energy drinks. Reference Link
07:21 EDTSLXPSalix submits response to FDA's CRL regarding XIFAXAN 550 mg tablets sNDA
Salix Pharmaceuticals announced that on August 29, it submitted its response to the March 7, 2011, FDA Complete Response Letter, or CRL, regarding the Company’s supplemental New Drug Application, or sNDA, for XIFAXAN 550 mg tablets for the proposed indication of the treatment of irritable bowel syndrome with diarrhea or IBS-D. Upon receipt of Salix’s response, the FDA will have six months to issue a response.
07:05 EDTAGOAssured Guaranty assumed with an Outperform at Keefe Bruyette
Subscribe for More Information
September 1, 2014
11:13 EDTUBNTStephens to hold an investor trip
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use